phenformin has been researched along with Neoplasm Metastasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akao, Y; Heishima, K; Honda, R; Ito, R; Ito, Y; Kuranaga, Y; Nakagawa, T; Nishikawa, M; Sakai, H; Soga, T; Sugito, N; Ueda, H | 1 |
| Albini, A; Bertolini, F; Calleri, A; Dallaglio, K; Gregato, G; Labanca, V; Mancuso, P; Noonan, DM; Orecchioni, S; Reggiani, F; Talarico, G | 1 |
| Choi, EK; Jang, SJ; Jo, SY; Jung, CL; Lee, C; Mun, H; Oh, JH; Suh, YA | 1 |
3 other study(ies) available for phenformin and Neoplasm Metastasis
| Article | Year |
|---|---|
Petasin potently inhibits mitochondrial complex I-based metabolism that supports tumor growth and metastasis.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Electron Transport Complex I; Endoplasmic Reticulum Stress; Female; Humans; Lung Neoplasms; Metabolome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasm Metastasis; Neoplasms, Experimental; Petasites; Phenformin; Sesquiterpenes; Unfolded Protein Response; Xenograft Model Antitumor Assays | 2021 |
The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Electron Transport Complex I; Female; Humans; Metformin; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Phenformin; Phosphorylation; TOR Serine-Threonine Kinases; Tumor Microenvironment | 2015 |
Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo.
Topics: A549 Cells; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxyglucose; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Humans; MAP Kinase Signaling System; Mice; Mutation; Neoplasm Metastasis; Neoplasms; Phenformin; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |